애임스바이오사이언스 애임스바이오사이언스
애임스바이오사이언스 애임스바이오사이언스


PMx 프로젝트 진행 현황
(2023년 3월 15일 기준)

애임스바이오사이언스 애임스바이오사이언스
Project No. Project Type Therapeutic Area Indication Stage Contact Pre-Meeting Contract Ongoing
MS-2022-024 Modeling
&
Simulation
Cell and Gene Therapy Hemophilia Clinical
MS-2022-027 Thrombotic Thrombocytopenic Purpura Non-Clinical
MS-2022-023 Endocrinology Obesity Clinical
MS-2022-010 Gastroenterology Gastroesophageal Reflux Disease Clinical
MS-2023-005 Hepatology Non-Alcoholic Steatohepatitis Clinical
MS-2022-021 Neurology Alzheimer’s Disease Non-Clinical
MS-2022-012 Oncology Cancer Clinical
MS-2022-016 Cancer Non-Clinical
MS-2022-018 Non-Small Cell Lung Cancer Clinical
MS-2022-020 Hematological Cancer Non-Clinical
MS-2022-025 Non-Small Cell Lung Cancer Clinical
MS-2022-028 FLT3-mutated Acute Myeloid Leukemia Non-Clinical
- - - -
NCA-2022-006 NCA (Noncompartmental Analysis) Cell and Gene Therapy Hemophilia Clinical
NCA-2022-002 Oncology Solid Tumor Clinical
NCA_2022_005 Solid Tumor Clinical
NCA-2023-001 Non-Small Cell
Lung Cancer
Clinical
NCA-2023-003 Ovarian Cancer Clinical
- - - -